Trials / Unknown
UnknownNCT01978470
External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy
External Trigeminal Nerve Stimulation for Epilepsy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- NeuroSigma, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the tolerability and safety of the NeuroSigma eTNS system.
Detailed description
This study evaluates the safety and tolerability of the NeuroSigma eTNS system for the treatment of drug resistent partial seizures. Up to 20 subjects, ages 18 - 75, with partial epilepsy will be enrolled in an acute 4-week tolerability study at Olive View/UCLA Medical Center ....... Enrolled subjects will be asked to maintain an accurate seizure calendar, and will be seen at the initial visit, then at two and four weeks.......
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | External Trigeminal Nerve Stimulation (eTNS) | External stimulation of the trigeminal nerve. |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2016-06-01
- Completion
- 2016-08-01
- First posted
- 2013-11-07
- Last updated
- 2016-04-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01978470. Inclusion in this directory is not an endorsement.